Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa

Oncology Reports

Volumn 13, Issue 3, 2005, Pages 497-502

  Kodama, Noriko ^a   Asakawa, Akihiro ^b   Inui, Akio ^b   Masuda, Yuki ^a   Nanba, Hiroaki ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxicity; Interleukin 12 receptor; Natural killer cell

Indexed keywords

INTERLEUKIN 12; PLANT EXTRACT; POLYSACCHARIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GRIFOLA; ISOLATION AND PURIFICATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; SECRETION;

ANIMALS; FEMALE; GRIFOLA; INTERLEUKIN-12; KILLER CELLS, NATURAL; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; PLANT EXTRACTS; POLYSACCHARIDES;

EID: 15044362783     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.3.497     Document Type: Article

References (31)

1. Wu J and Lanier LL: Natural killer cells and cancer. Adv Cancer Res 90: 127-156, 2003. (Pubitemid 37549223)
2. Cooper MA, Fehniger TA and Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640, 2001. (Pubitemid 33043908)
3. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M and Trinchieri G: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161: 5821-5824, 1998. (Pubitemid 28535946)
4. Robertson MJ: Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71: 173-183, 2002.
5. Germann T and Rude E: Interleukin-12. Int Arch Allergy Immunol 108: 103-112, 1995.
6. Rajshekhar S and Alli Ashok K: Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function. FEBS Lett 559: 71-76, 2004.
7. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276, 1995.
8. Cesano A, Visonneau S, Clark SC and Santoli D: Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 151: 2943-2257, 1993.
9. Salcedo TW, Azzoni L, Wolf SF and Perussia B: Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 151: 2511-2520, 1993. (Pubitemid 23264503)
10. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF and Gately MK: Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 153: 128-136, 1994. (Pubitemid 24186525)
11. Chua AO, Wilkinson VL, Presky DH and Gubler U: Cloning and characterization of a mouse IL-12 receptor-beta component. J Immunol 155: 4286-4294, 1995.
12. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK and Gubler UA: functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 93: 14002-14007, 1996.
13. Yamamoto K, Shibata F, Miyasaka N and Miura O: The human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells. Biochem Biophys Res Commun 297: 1245-1252, 2002. (Pubitemid 35216381)
14. Borchers AT, Stern JS, Hackman RM, Keen CL and Gershwin ME: Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 221: 281-293, 1999. (Pubitemid 29386016)
15. Nanba H, Hamaguchi A and Kuroda H: The chemical structure of an antitumor polysaccharide in fruit bodies of Grifola frondosa (maitake). Chem Pharm Bull 35: 162-168, 1987.
16. Adachi K, Nanba H and Kuroda H: Potentiation of host-mediated antitumor activity in mice by β-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull 35: 262-270, 1987. (Pubitemid 17021391)
17. Hishida I, Nanba H and Kuroda H: Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake). Chem Pharm Bull 36: 1819-1827, 1987.
18. Inoue A, Kodama N and Nanba H: Effect of maitake (Grifola frondosa) D-Fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 25: 536-540, 2002. (Pubitemid 40036751)
19. Kodama N, Harada N and Nanba H: A polysaccharide, extract from Grifola frondosa, induced Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 90: 357-360, 2002. (Pubitemid 36096892)
20. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF and Gately MK: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178: 1223-1230, 1993. (Pubitemid 23277355)
21. Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW and Tao MH: Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene. J Biomed Sci 10: 73-86, 2003.
22. Nastala CL, Edington HD, Mckinney TG, Tahara H, Nalesnik MA, Brunda MJ, GAtely MK, Wolf SF, Schreiber RD and Storkus WJ: Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153: 1697-1706, 1994. (Pubitemid 24251114)
23. Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM and Hamilton TA: Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J Immunol 156: 693-699, 1996. (Pubitemid 26029621)
24. Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW and Cao X: Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Titer 9: 793-803, 2002. (Pubitemid 34679307)
25. Decker T and Lohmann-Matthes ML: A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115: 61-69, 1988.
26. Boehm U, Klamp T, Groot M and Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795, 1997.
27. Kodama N, Kakuno T and Nanba H: Stimulation of the natural immune system in normal mice by polysaccharide from maitake mushroom. Mycoscience 44: 257-261, 2003. (Pubitemid 36990221)
28. Marzio R, Mauel J and Betz-Corradin S: CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 21: 565-582, 1999. (Pubitemid 29409367)
29. Tribal F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequifnot E and Hercend T: LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171: 1393-1405, 1990. (Pubitemid 20167538)
30. Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT and Tahara H: Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J Immunol 163: 583-589, 1999. (Pubitemid 29328059)
31. Wallin RP, Screpanti V, Michaelsson J, Grandien A and Ljunggren HG: Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 33: 727-735, 2003.